Change search
ReferencesLink to record
Permanent link

Direct link
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
Show others and affiliations
2010 (English)In: Journal of Hypertension, ISSN 0263-6352, E-ISSN 1473-5598, Vol. 28, no 7, 1366-1372 p.Article in journal (Refereed) Published
Abstract [en]

Background: Results of randomized controlled trials are consistent in showing reduced rates of stroke, heart failure and cardiovascular events in very old patients treated with antihypertensive drugs. However, inconsistencies exist with regard to the effect of these drugs on total mortality.

Methods: We performed a meta-analysis of available data on hypertensive patients 80 years and older by selecting total mortality as the main outcome. Secondary outcomes were coronary events, stroke, cardiovascular events, heart failure and cause-specific mortality. The common relative risk (RR) of active treatment versus placebo or no treatment was assessed using a random-effect model. Linear meta-regression was performed to explore the relationship between intensity of antihypertensive therapy and blood pressure (BP) reduction and the log-transformed value of total mortality odds ratios (ORs).

Results: The overall RR for total mortality was 1.06 (95% confidence interval 0.89–1.25), with significant heterogeneity between hypertension in the very elderly trial (HYVET) and the other trials. This heterogeneity was not explained by differences in the follow-up duration between trials. The meta-regression suggested that a reduction in mortality was achieved in trials with the least BP reductions and the lowest intensity of therapy. Antihypertensive therapy significantly reduced (P < 0.001) the risk of stroke (35%), cardiovascular events (27%) and heart failure (50%). Cause-specific mortality was not different between treated and untreated patients.

Conclusion: Treating hypertension in very old patients reduces stroke and heart failure with no effect on total mortality. The most reasonable strategy is the one associated with significant mortality reduction; thiazides as first-line drugs with a maximum of two drugs.

Place, publisher, year, edition, pages
2010. Vol. 28, no 7, 1366-1372 p.
Keyword [en]
80 and over, aged, antihypertensive therapy, heart failure, hypertension, intensity of therapy, meta-analysis, mortality, stroke
National Category
Cardiac and Cardiovascular Systems
URN: urn:nbn:se:umu:diva-41554DOI: 10.1097/HJH.0b013e328339f9c5ISI: 000279579800003OAI: diva2:406828
Available from: 2011-03-28 Created: 2011-03-28 Last updated: 2011-12-14Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Lindholm, Lars H
By organisation
Family Medicine
In the same journal
Journal of Hypertension
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 102 hits
ReferencesLink to record
Permanent link

Direct link